Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis.

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis.

Item
http://www.wikidata.org/entity/Q37893470
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature reviewOnce-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysisIndacaterol: a comprehensive review.Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis.Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies.The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD.Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.The role of indacaterol for chronic obstructive pulmonary disease (COPD).Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.Systematic review comparing LABA, olodaterol, and indacaterol: limitations.Indacaterol for the treatment of chronic obstructive pulmonary disease.
P2860

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis.

Item
http://www.wikidata.org/entity/Q37893470
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@en
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@nl
type
label
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@en
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@nl
prefLabel
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@en
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932
P356
P1433
P1476
Comparative efficacy of indaca ...... ease--a network meta-analysis.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932